| Financial Year |
March 31 2022 |
| Monetary Funds |
330,523,487.53 |
| Held-for-trading Financial Assets |
458,685,258.48 |
| Notes Receivable |
-- |
| Accounts Receivable |
696,200,889.90 |
| Advances to Suppliers |
46,318,524.54 |
| Other Receivables |
32,491,599.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
173,369,920.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,321,561.39 |
| Total Current Assets |
1,760,911,242.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,828,603.73 |
| Fixed Assetes |
118,960,834.72 |
| Under-construction Projects |
2,575,250.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,465,153.82 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
686,324.72 |
| Deferred Income Tax Assets |
12,407,791.15 |
| Other Non-Current Assets |
4,107,432.69 |
| Sub-Total of Non-Current Assets |
148,333,832.10 |
| Total Assets |
1,909,245,074.50 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
282,084,093.60 |
| Accounts Payable |
386,429,046.83 |
| Accounts Received In Advance |
12,964,657.88 |
| Employee Compensation Payable |
11,090,369.74 |
| Taxes Payable |
33,151,708.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,095,359.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
330,337.62 |
| Other Current Liabilities |
60,423.38 |
| Sub-Total of Current Liabilities |
787,651,320.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,043,413.98 |
| Deferred Income Tax Liabilities |
989,955.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,745,986.05 |
| Total Liabilities |
790,397,306.65 |
| Paid-In Capital(Or Share Stock) |
194,240,000.00 |
| Capital Surplus |
583,706,734.35 |
| Surplus Reserve |
37,288,911.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
313,058,937.45 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,118,847,767.85 |
| Owner's Equity（Stockholder's Equity） |
1,118,847,767.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,909,245,074.50 |
